OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contents
Following successful completion of Phase 1, Ares Genetics has now entered into Phase 2 of its collaboration with a leading U.S. CRO and reference lab, gaining access to 1,000 proprietary clinical isolates from key pathogensARESdb contents…